NEUROG3 and cancer: Pancreatic ACC was detected in 66.7% of Ngn3-Tsc1−/− mice fed HFD at 84-days-old, whereas the transgenic mice fed NCD demonstrated no detectable cancer at this age (Fig. 5a).